<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02387060</url>
  </required_header>
  <id_info>
    <org_study_id>13-389</org_study_id>
    <nct_id>NCT02387060</nct_id>
  </id_info>
  <brief_title>Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean</brief_title>
  <official_title>Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid analgesic drugs are the main treatment of patients during anesthesia. Although highly
      effective, their use is not without problems. One is the increasing requirement of these
      address the same nociceptive stimulus.

      Opioid induced hyperalgesia could be an explanation studies in animal models. Through
      mechanisms where N-methyl-D-aspartate receptors, glutamatergic system disturbances and
      changes in intracellular calcium regulation involved.

      The hyperalgesia induced by intrathecal opioids is controversial. The investigators propose a
      model study in patients undergoing cesarean section to study the secondary hyperalgesia
      induced based on the study of nociceptive thresholds with two methods opioids: Von Frey
      filaments and digital algometer.

      If intrathecal fentanyl is used in spinal anesthesia for elective cesarean section, then, an
      increase in sensitivity will occur. This increase can be measured by von Frey filaments,
      expressed in increased requirement clinically opioids.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Punctate - Von frey (grams)</measure>
    <time_frame>Change from Baseline in punctate sensibility at 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Pressure pain - algometer (kg/cm/cm)</measure>
    <time_frame>Change from Baseline in pressure pain at 48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Complications; Cesarean Section</condition>
  <arm_group>
    <arm_group_label>H-Bupivacaine 11.5 mg + fentanyl 25 mcg.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intrathecal administration of Hyperbaric Bupivacaine 1.5 ml 0.75% plus fentanyl 25 mcg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>H-Bupivacaine 11.5 mg.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intrathecal administration of Hyperbaric Bupivacaine 1.5 ml 0.75%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>H-Bupivacaine</intervention_name>
    <description>Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%</description>
    <arm_group_label>H-Bupivacaine 11.5 mg + fentanyl 25 mcg.</arm_group_label>
    <arm_group_label>H-Bupivacaine 11.5 mg.</arm_group_label>
    <other_name>Hyperbaric bupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Intrathecal administration of fentanyl 25 mcg</description>
    <arm_group_label>H-Bupivacaine 11.5 mg + fentanyl 25 mcg.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant 37 to 41 weeks.

          -  American Society of Anesthesiologists classificationI or II.

          -  Between 18 and 40 years.

          -  Scheduled for elective cesarean section under spinal anesthesia in the Maternity
             Service of the Clinical Hospital of the Catholic University.

        Exclusion Criteria:

          -  Background Of high risk pregnancy. Twin-pregnancy.

          -  Obesity&gt; 30 kg / m 2 before pregnancy.

          -  Background Of psychiatric illness.

          -  Using Chronic analgesic.

          -  AllergyDrug used in protocol.

          -  require General anesthesia during surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis I Cortinez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ponticia Universidad Católica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Carlos De la Cuadra, MD</last_name>
    <phone>+56-2-23543270</phone>
    <email>juancarl@med.puc.cl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hernan Auad, MD</last_name>
    <phone>+56-2-23543270</phone>
    <email>hernan_auad@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clinico Pontificia Universidad Catolica</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <zip>8330024</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hernan Auad, MD</last_name>
      <phone>56982933226</phone>
      <email>hernan_auad@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Carlos de la Cuadra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2015</study_first_submitted>
  <study_first_submitted_qc>March 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2015</study_first_posted>
  <last_update_submitted>March 7, 2015</last_update_submitted>
  <last_update_submitted_qc>March 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Spinal and Epidural</keyword>
  <keyword>Adverse Effect</keyword>
  <keyword>Complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

